Resistance to doxorubicin (DOX) is mainly due to the effect of P-glyco
protein encoded by the multidrug resistance (MDR) gene. Cepharanthine
(CEP) has been shown to circumvent multidrug resistance in P-glycoprot
ein-expressing cell lines. In the present study, we investigated the a
ugmentation of DOX sensitivity by CEP using an MTT assay, and assessed
the correlation between DOX sensitivity and P-glycoprotein expression
by flow cytometry, in highly purified fresh human tumor cells obtaine
d from 73 cancer patients. DOX sensitivity was decreased in proportion
to P-glycoprotein expression. The cytotoxicity of DOX was increased b
y CEP in tumor cells possessing low DOX P-glycoprotein sensitivity. Mo
reover, there was a significant correlation between the effect of Doxo
rubicin CEP on cytotoxicity and P-glycoprotein expression. Thus, CEP m
ight be able Cepharanthine to circumvent DOX resistance in cancer pati
ents.